Canton Hathaway’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-225
| Closed | -$21K | – | 255 |
|
|
2024
Q2 | $21K | Hold |
225
| – | – | 0.01% | 235 |
|
|
2024
Q1 | $22K | Sell |
225
-90
| -29% | -$8.8K | 0.01% | 238 |
|
|
2023
Q4 | $24K | Hold |
315
| – | – | 0.01% | 218 |
|
|
2023
Q3 | $22K | Hold |
315
| – | – | 0.01% | 213 |
|
|
2023
Q2 | $30K | Hold |
315
| – | – | 0.01% | 191 |
|
|
2023
Q1 | $26K | Hold |
315
| – | – | 0.01% | 205 |
|
|
2022
Q4 | $24K | Hold |
315
| – | – | 0.01% | 210 |
|
|
2022
Q3 | $26K | Hold |
315
| – | – | 0.01% | 195 |
|
|
2022
Q2 | $30K | Hold |
315
| – | – | 0.01% | 207 |
|
|
2022
Q1 | $37K | Hold |
315
| – | – | 0.01% | 204 |
|
|
2021
Q4 | $41K | Hold |
315
| – | – | 0.01% | 207 |
|
|
2021
Q3 | $36K | Buy |
+315
| New | +$36K | 0.01% | 216 |
|
|
2021
Q2 | – | Sell |
-90
| Closed | -$8K | – | 271 |
|
|
2021
Q1 | $8K | Hold |
90
| – | – | ﹤0.01% | 246 |
|
|
2020
Q4 | $8K | Hold |
90
| – | – | ﹤0.01% | 217 |
|
|
2020
Q3 | $7K | Hold |
90
| – | – | ﹤0.01% | 266 |
|
|
2020
Q2 | $6K | Buy |
+90
| New | +$6K | ﹤0.01% | 146 |
|
|
2020
Q1 | – | Sell |
-1,290
| Closed | -$100K | – | 162 |
|
|
2019
Q4 | $100K | Hold |
1,290
| – | – | 0.05% | 103 |
|
|
2019
Q3 | $95K | Hold |
1,290
| – | – | 0.05% | 104 |
|
|
2019
Q2 | $79K | Buy |
1,290
+90
| +8% | +$5.51K | 0.04% | 108 |
|
|
2019
Q1 | $76K | Hold |
1,200
| – | – | 0.04% | 108 |
|
|
2018
Q4 | $61K | Hold |
1,200
| – | – | 0.04% | 103 |
|
|
2018
Q3 | $70K | Buy |
+1,200
| New | +$70K | 0.04% | 88 |
|